Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease

被引:6
|
作者
Katagishi, Daiki [1 ]
Yasuda, Daisuke [1 ]
Takahashi, Kyoko [2 ]
Nakamura, Shigeo [2 ]
Mashino, Tadahiko [1 ]
Ohe, Tomoyuki [1 ]
机构
[1] Keio Univ, Fac Pharm, Dept Pharmaceut Sci, 1-5-30 Shibakoen,Minato Ku, Tokyo, Japan
[2] Nippon Med Sch, Dept Chem, 1-7-1 Kyonan Cho,Musashino, Tokyo, Japan
关键词
Fullerene; COVID-19; SARS-CoV-2; Main protease; REVERSE TRANSCRIPTASE INHIBITION; C-60; POLYMERASE;
D O I
10.1016/j.bmcl.2022.129121
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
COVID-19 is an ongoing worldwide pandemic. Even today, there is a need for the development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of COVID-19, and its main protease is one of the enzymes essential for its growth and is considered a drug discovery target. In this study, we evaluated the inhibitory activities of a variety of fullerene derivatives, including newly synthesized derivatives, against the main protease of SARS-CoV-2. As a result, the malonic acid-type fullerene derivatives showed the strongest inhibitory activity.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Zinc thiotropolone combinations as inhibitors of the SARS-CoV-2 main protease
    DeLaney, Christopher
    Sheng, Yan
    Pectol, D. Chase
    Vantansever, Erol
    Zhang, Hanyuan
    Bhuvanesh, Nattamai
    Salas, Isaiah
    Liu, Wenshe R.
    Fierke, Carol F.
    Darensbourg, Marcetta Y.
    DALTON TRANSACTIONS, 2021, 50 (35) : 12226 - 12233
  • [22] De novo Design of SARS-CoV-2 Main Protease Inhibitors
    Fischer, Christian
    Veprek, Nynke A.
    Peitsinis, Zisis
    Ruhmann, Klaus-Peter
    Yang, Chao
    Spradlin, Jessica N.
    Dovala, Dustin
    Nomura, Daniel K.
    Zhang, Yingkai
    Trauner, Dirk
    SYNLETT, 2022, 33 (05) : 458 - 463
  • [23] Investigating the Inhibition of Diindolylmethane Derivatives on SARS-CoV-2 Main Protease
    Li, Wenjin
    Chang, Xiaoyu
    Zhou, Hang
    Yu, Wenquan
    Wang, Ruiyong
    Chang, Junbiao
    JOURNAL OF MOLECULAR RECOGNITION, 2024, 37 (06)
  • [24] Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach
    Lima, Adrianne M.
    de Souza, Adson A.
    Amaral, Jackson L.
    Freire, Valder N.
    Souza, Pedro F.
    de Oliveira, Hermogenes D.
    FUTURE VIROLOGY, 2023, 18 (07) : 439 - 454
  • [25] Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro)
    Azevedo, Pedro Henrique R. de A.
    Camargo, Priscila G.
    Constant, Larissa E. C.
    Costa, Stephany da S.
    Silva, Celimar Sinezia
    Rosa, Alice S.
    Souza, Daniel D. C.
    Tucci, Amanda R.
    Ferreira, Vivian N. S.
    Oliveira, Thamara Kelcya F.
    Borba, Nathalia R. R.
    Rodrigues, Carlos R.
    Albuquerque, Magaly G.
    Dias, Luiza R. S.
    Garrett, Rafael
    Miranda, Milene D.
    Allonso, Diego
    Lima, Camilo Henrique da S.
    Muri, Estela Maris F.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS-CoV-2 main protease
    de Carvalho, Maryelle A. G.
    Souza, Gabriella B.
    Tizziani, Tiago
    Pontes, Carime L. M.
    Dambros, Bibiana P.
    de Sousa, Natalia F.
    Scotti, Marcus T.
    Steindel, Mario
    Braga, Antonio L.
    Sandjo, Louis P.
    de Assis, Francisco F.
    ARCHIV DER PHARMAZIE, 2024, 357 (11)
  • [27] SARS-CoV-2 Main Protease as Target
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1278 - 1278
  • [28] Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors
    Gao, Shenghua
    Song, Letian
    Claff, Tobias
    Woodson, Molly
    Sylvester, Katharina
    Jing, Lanlan
    Weisse, Renato H.
    Cheng, Yusen
    Straeter, Norbert
    Schaekel, Laura
    Guetschow, Michael
    Ye, Bing
    Yang, Mianling
    Zhang, Tao
    Kang, Dongwei
    Toth, Karoly
    Tavis, John
    Tollefson, Ann E.
    Mueller, Christa E.
    Zhan, Peng
    Liu, Xinyong
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 16902 - 16917
  • [29] Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study
    Refaey, Rana H.
    El-Ashrey, Mohamed K.
    Nissan, Yassin M.
    VIROLOGY, 2021, 554 : 48 - 54
  • [30] Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
    Baev, Dmitry S.
    Blokhin, Mikhail E.
    Chirkova, Varvara Yu.
    Belenkaya, Svetlana V.
    Luzina, Olga A.
    Yarovaya, Olga I.
    Salakhutdinov, Nariman F.
    Shcherbakov, Dmitry N.
    MOLECULES, 2023, 28 (01):